In a historic move, the World Health Organization (WHO) has finalized the world’s first global pandemic treaty—without the participation of the United States. As reported by Nature, the treaty establishes a framework for countries to better prevent, prepare for, and respond to future pandemics, with a focus on equity and global solidarity.
After more than three years of tense negotiations in Geneva, the agreement sets the stage for a new system of pathogen access and benefit sharing. Under the accord, pharmaceutical companies will gain access to critical scientific data—such as virus samples and genome sequences—in exchange for commitments to distribute at least 20% of their vaccines, drugs, and diagnostics to the WHO during pandemics. This aims to address the stark inequalities seen during COVID-19, when many low- and middle-income countries were left behind.
“This is a definitive moment in the history of global health,” said Lawrence Gostin, a global health law expert at Georgetown University. While the U.S. absence is a “gaping hole,” Gostin noted that the unity of other nations in the face of American withdrawal—sparked by former President Trump—underscores the world’s commitment to multilateralism.
The treaty also calls for the promotion of technology and knowledge sharing, especially to empower developing nations to manufacture their own medical supplies. Countries are encouraged to attach conditions to publicly funded research, ensuring that treatments and vaccines are affordable, accessible, and transparently developed.
Despite the breakthrough, many practical elements of the treaty still need to be worked out, and the draft must be ratified by WHO member states. Industry groups have expressed concerns about ensuring the treaty balances innovation incentives with access obligations. As Nature notes, the treaty represents a rare convergence of political will, driven in part by a global determination not to repeat the mistakes of the COVID-19 response.
While the U.S. exit casts a shadow over the pact’s potential reach, global health advocates see it as a bold step toward a more cooperative future. “In this gloomy political environment, this gives us hope,” said Precious Matsoso, co-chair of the WHO body that led the negotiations.
